AIMOVIG vs SERPASIL-ESIDRIX #1

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. AIMOVIG and SERPASIL-ESIDRIX #1 are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	SERPASIL-ESIDRIX #1
Rating	72/100	70/100
Pharmacy pays	—	~$0.91 /30
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	HYDROCHLOROTHIAZIDE AND RESERPINE
Manufacturer	Amgen Inc	Novartis
Dosage forms	Injectable, Solution	Tablet
Drug class	—	—
Boxed warning	None	None
Half-life	—	about 6 to 15 hours (the label reports a range, not a single number)

aimovig serpasil-esidrix #1

Rating

72/100

70/100

Pharmacy pays

—

~$0.91 /30

Type

Active ingredient

ERENUMAB-AOOE

HYDROCHLOROTHIAZIDE AND RESERPINE

Manufacturer

Amgen Inc

Novartis

Dosage forms

Injectable, Solution

Tablet

Drug class

—

Boxed warning

None

Half-life

—

about 6 to 15 hours (the label reports a range, not a single number)

Frequently asked questions

Which is better-rated, Aimovig or Serpasil-Esidrix #1?

By our independent rating, Aimovig scores higher — 3.6 vs 3.5 out of 5 for Serpasil-Esidrix #1. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Aimovig and Serpasil-Esidrix #1?

Aimovig contains Erenumab-Aooe, while Serpasil-Esidrix #1 contains Hydrochlorothiazide and Reserpine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.